Spinal Cord Infarction Follow-up
- Author: Thomas F Scott, MD; Chief Editor: Helmi L Lutsep, MD more...
Further Outpatient Care
Treat persisting spasticity, which may be manifest by painful cramps and/or spasms, with oral baclofen, tizanidine, or occasionally diazepam. If the spasticity is unrelieved and remains symptomatic with manifestations such as stiffness, limited gait, spasms, cramps, and pain, proceed to interventional measures; the most successful are intramuscular injection of botulinum toxin and intrathecal baclofen by subarachnoid pump.
Impotence may respond to oral sildenafil (or related phosphodiesterase-5 inhibitors). The dose of sildenafil is 50 mg (not to exceed 100 mg) taken 30-45 minutes before sexual activity. Intervention by intraurethral alprostadil or intracavernous injection of alprostadil also may be effective.
One can manage urinary incontinence and urgency with oral oxybutynin. It is also available as a slow-release capsule (Ditropan XL). Detrol (tolterodine) or Detrol LA is a newer drug effective in the treatment of overactive bladder.
Further Inpatient Care
The patient is evaluated by the rehabilitation or physiatry service. Episodes of infarction are usually single or monophasic with a low frequency of recurrence, although this can depend on the etiology of the ischemic cord lesion. The prognosis for functional recovery should be guarded in light of the series in the medical literature. A minority of patients improve; rarely (< 10%), patients achieve a remarkable recovery of function, particularly of motor control and ability to walk. A transition to semi-independent living is accomplished through intense rehabilitation efforts.
Inpatient & Outpatient Medications
Persisting spasticity can be alleviated with conventional measures beginning with oral baclofen, tizanidine, and occasionally diazepam. If these measures are ineffectual, intramuscular botulinum toxin or intrathecal baclofen by subarachnoid pump can be recommended.
The acute stage involves an urgency for diagnosis and the necessity for excluding emergency spinal decompressive surgery that mandates admission to a major center or hospital facility with the requisite imaging, neurosurgical, and related capabilities.
Neurologic and other disability is usually either permanent or slowly resolving. Hence, long-term care in a rehabilitation hospital or equivalent facility is the best setting once the acute phase is complete and the patient is medically stable. Transfer to this service should be a goal established early in the planning. The optimum setting for maximal and efficient recovery is the clinical unit devoted to spinal cord disorder or injury.
Spinal cord ischemia and infarction are determined by vascular risk. Diabetes mellitus is common in this disorder, affecting approximately 50% of patients. As is generally the case for the tertiary complications of diabetes, strict control of blood glucose to minimize the resultant arteriolosclerosis reduces the risk of spinal cord infarction. Giant cell arteritis should be considered particularly in elderly persons and if headache, elevated ESR, or concurrent visual symptoms is present.
Other vascular risk factors including hyperlipidemia, hypertension, and arteritis of numerous types, including dysimmune, syphilis, and "vascular fungi" such as mucormycosis, may predispose patients to spinal cord infarction. Appropriate management of these risk factors is recommended for prophylaxis for future vascular complications.
Immobility stemming from the paresis and paralysis has a host of medical consequences of which the more common and serious are venous stasis, thrombosis and pulmonary embolus, pneumonia, and decubitus ulcer.
Spinal cord ischemia (and its irreversible tissue injury of infarction) is a myelopathy, generally associated with substantial motor, sensory, and bladder and/or bowel dysfunction. The short-term mortality rate is 20-25% over the first month following onset of symptoms. The overall life expectancy is diminished because of the vascular, infectious, and other medical complications. The striking improvement in medical care and rehabilitation has led to an improvement in quality of life for patients with spinal cord strokes since World War II. A 2012 study of 115 patients with spinal cord infarct found that patients experienced gradual improvement after the event. At 3-year follow-up, 41% of patients using a wheelchair at hospital dismissal were walking and 33% of patients catheterized at dismissal were catheter-free.
Because the extent of damage is less than that sustained in most traumatic cord injuries, and the potential for recovery is greater because ischemia is reversible in part, these patients may have better function than patients with traumatic cord injuries though the prognosis for substantial motor recovery should be guarded.
Those at risk of spinal ischemia cannot be differentiated readily from those at risk of more common disorders of the circulation such as cerebrovascular stroke, myocardial infarction, and renal failure. The measures recommended to reduce these vascular disorders also reduce the incidence and occurrence of myelomalacia. Hence, education of those bearing a treatable vascular risk in regard to diabetic treatment, aspirin prophylaxis, antihypertensive agents, and immunomodulatory therapy logically can be expected to be of benefit and reduce the incidence of spinal thrombosis.
Cheshire WP, Santos CC, Massey EW, Howard JF Jr. Spinal cord infarction: etiology and outcome. Neurology. 1996 Aug. 47(2):321-30. [Medline].
Salvador de la Barrera S, Barca-Buyo A, Montoto-Marques A. Spinal cord infarction: prognosis and recovery in a series of 36 patients. Spinal Cord. 2001 Oct. 39(10):520-5. [Medline].
Combarros O, Vadillo A, Gutierrez-Perez R. Cervical spinal cord infarction simulating myocardial infarction. Eur Neurol. 2002. 47(3):185-6. [Medline].
Weber P, Vogel T, Bitterling H, Utzschneider S, von Schulze Pellengahr C, Birkenmaier C. Spinal cord infarction after operative stabilisation of the thoracic spine in a patient with tuberculous spondylodiscitis and sickle cell trait. Spine. 2009 Apr 15. 34(8):E294-7. [Medline].
Joseph G, Santosh C, Marimuthu R. Spinal cord infarction due to a self-inflicted needle stick injury. Spinal Cord. 2004 Nov. 42(11):655-8. [Medline].
Hogan EL, Romanul FC. Spinal cord infarction occurring during insertion of aortic graft. Neurology. 1966 Jan. 16(1):67-74. [Medline].
Ross RT. Spinal cord infarction in disease and surgery of the aorta. Can J Neurol Sci. 1985 Nov. 12(4):289-95. [Medline].
Faivre A, Bonnel S, Leyral G, Gisserot O, Alla P, Valance J. [Essential thrombocythemia presenting as spinal cord infarction.]. Presse Med. 2009 Apr 22. [Medline].
Lyders EM, Morris PP. A Case of Spinal Cord Infarction Following Lumbar Transforaminal Epidural Steroid Injection: MR Imaging and Angiographic Findings. AJNR Am J Neuroradiol. 2009 Apr 15. [Medline].
Zhang J, Huan Y, Qian Y. Multishot diffusion-weighted imaging features in spinal cord infarction. J Spinal Disord Tech. 2005 Jun. 18(3):277-82. [Medline].
Vijayan N, Peacock JH. Spinal cord infarction during use of zolmitriptan: a case report. Headache. 2000 Jan. 40(1):57-60. [Medline].
Sandson TA, Friedman JH. Spinal cord infarction. Report of 8 cases and review of the literature. Medicine (Baltimore). 1989 Sep. 68(5):282-92. [Medline].
Satran R. Spinal cord infarction. Stroke. 1988 Apr. 19(4):529-32. [Medline].
Tosi L, Rigoli G, Beltramello A. Fibrocartilaginous embolism of the spinal cord: a clinical and pathogenetic reconsideration. J Neurol Neurosurg Psychiatry. 1996 Jan. 60(1):55-60. [Medline]. [Full Text].
Weidauer S, Nichtweiss M, Lanfermann H. Spinal cord infarction: MR imaging and clinical features in 16 cases. Neuroradiology. 2002 Oct. 44(10):851-7. [Medline].
Luo CB, Chang FC, Teng MM. Magnetic resonance imaging as a guide in the diagnosis and follow-up of spinal cord infarction. J Chin Med Assoc. 2003 Feb. 66(2):89-95. [Medline].
KÃ¼ker W, Weller M, Klose U. Diffusion-weighted MRI of spinal cord infarction--high resolution imaging and time course of diffusion abnormality. J Neurol. 2004 Jul. 251(7):818-24. [Medline].
Shinoyama M, Takahashi T, Shimizu H. Spinal cord infarction demonstrated by diffusion-weighted magnetic resonance imaging. J Clin Neurosci. 2005 May. 12(4):466-8. [Medline].
Thomas T, Branson HM, Verhey LH, Shroff M, Stephens D, Magalhaes S, et al. The Demographic, Clinical, and Magnetic Resonance Imaging (MRI) Featuresof Transverse Myelitis in Children. J Child Neurol. 2012;27:11-21. 1. 27:11-21. [Full Text].
Robertson CE, Brown RD Jr, Wijdicks EF, Rabinstein AA. Recovery after spinal cord infarcts: Long-term outcome in 115 patients. Neurology. 2012 Jan 10. 78(2):114-21. [Medline].
Castro-Moure F, Kupsky W, Goshgarian HG. Pathophysiological classification of human spinal cord ischemia. J Spinal Cord Med. 1997 Jan. 20(1):74-87. [Medline].
Cheng MY, Lyu RK, Chang YJ, Chen CM, Chen ST, Wai YY, et al. Concomitant spinal cord and vertebral body infarction is highly associated with aortic pathology: a clinical and magnetic resonance imaging study. J Neurol. 2009 Apr 28. [Medline].
Cheshire WP Jr. Spinal cord infarction mimicking angina pectoris. Mayo Clin Proc. 2000 Nov. 75(11):1197-9. [Medline].
Cunningham JN. Spinal cord ischemia. Semin Thorac Cardiovasc Surg. 1973. 10:3-5.
Di Chiro G, Herdt JR. Angiographic demonstration of spinal cord arterial occlusion in postradiation myelomalacia. Radiology. 1973 Feb. 106(2):317-9. [Medline].
Garland H, Greenberg J, Harriman DG. Infarction of the spinal cord. Brain. 1966 Dec. 89(4):645-62. [Medline].
Gass A, Back T, Behrens S, Maras A. MRI of spinal cord infarction. Neurology. 2000 Jun 13. 54(11):2195. [Medline].
Hogan EL, Dale AJD. Disorders of the spinal cord. In: Clinical Medicine. Vol 10. 1982:1-36.
Laguna J, Cravioto H. Spinal cord infarction secondary to occlusion of the anterior spinal artery. Arch Neurol. 1973 Feb. 28(2):134-6. [Medline].
Leite I, Monteiro L. Spinal cord infarction. Neurology. 1997 May. 48(5):1478. [Medline].
Wheeler HB, O'Donnell JA, Anderson FA. Bedside screening for venous thrombosis using occlusive impedance phlebography. Angiology. 1975 Feb. 26(2):199-210. [Medline].
Young G, Krohn KA, Packer RJ. Prothrombin G20210A mutation in a child with spinal cord infarction. J Pediatr. 1999 Jun. 134(6):777-9. [Medline].